Short course radiation therapy for prostate cancer https://t.co/jZl8aCMXL3

Expanding The Beam - A New Podcast I’m excited to share that Dr. Richard Shaffer and I are launching a new podcast centered on one of the fastest-growing areas in our specialty: Benign Radiotherapy (also called Functional Radiotherapy). This space is evolving quickly not only

Finally, the OPPS Final Rule Hospitals Took the L on this one with what was wanted.

Today marked a powerful moment in the early days of launching the Functional Radiotherapy Program at Loyola University Chicago Stritch School of Medicine Tinley Park. I evaluated a post-operative knee OA patient who has endured over a year of relentless, debilitating pain. His

Add this to the list of misleading reports from lay media who burry in the article the higher recurrence rates and salvage therapy rates from IORT and try to spin this as a new technology trying to be blocked out. Been around for over 25 years.

5. At the end of a week like this, I’m reminded: ICU medicine is about skill but also about presence, humility, and humanity. Grateful to do this work alongside dedicated colleagues and trainees who bring those values to the bedside every day.

Join us for the second PULSAR Consortium Meeting at @ASTRO_org on Monday, September 29, at 6 p.m! This special meeting will feature in-depth discussions with leading experts on PULSAR in clinical practice. Register and learn more in the link below. 🔗: https://t.co/aJsQ4X5qA7

We are thrilled to continue to be a leading center in radiation oncology with another very exciting collaboration to be the first in the USA to have the most advanced rotational arc cobalt SRS unit available to date (Akesis Galaxy RTI), combined with our amazing LINAC SRS

🚨Proposed CMS Cuts to Orthovoltage Radiotherapy for Benign Conditions —A Threat to Patient Care and Specialty Sustainability The newly proposed CMS rules would slash reimbursement for orthovoltage radiotherapy—used for benign conditions like osteoarthritis — by a nearly 40%

Straight talk on @ValHealthVoices podcast on the implications of the @CMSGov #MPFS and #HOPPS proposed rules and their effect on procedural-based specialities with special focus on #radonc Special thanks to @ASTRO_org and @ACRORadOnc presidents @SameerKeoleMD and @blally_md for

Just a friendly reminder: The early registration deadline for our upcoming AI Medicine Symposium (September 26-27) and Modern Proton Therapy Symposium (September 27) is July 25. Be sure to pre-register here: https://t.co/FFLjpfCJs0

Here is the URL for registration of our CME symposia. The first symposium will focus on AI Foundation Models and Agentic AI for Radiation Oncology and Healthcare. The second, held exclusively on Saturday, will cover Modern Proton Radiation Therapy https://t.co/FFLjpfCJs0

Exciting to bring the tech to USA. I hope the lessons on proton are not repeated. Over 40,000 patients have been treated with carbon ion worldwide. Unclear what cancers this enhances your ability to treat. It is ok to bring new tech and do research with it and not claim it is

Quote of the day: Physicians, academics, and regulators should be the stewards of integrity, tasked with carefully holding the line between discovery, patient/society benefit, and industry’s financial benefit. When physicians blur that boundary under the banner of scholarship,

A symposium focusing on AI foundation models, generative models, and agentic AI will be held on Stanford campus before ASTRO annual meeting in SF. Please mark your calendars; detailed program and registration website for the symposium will be made available online soon.

@JoeBiden @SocialSecurity @theNCI @CNN @lkayat @jeshoag @MUSICUrology @jimhumd @TylerSbrt 12/12 Summary, men >70yo absolutely can benefit from personalized screening. A) Comorbidities/life expectancy should be estimated B) PSA should be used to guide screening based on A C) MRI should be used based on A and B D) Biopsy should be used based on A-C -Observation or PSA

Missing some faculty but great meeting ⁦@RadOncUH⁩ overlooking the University Circle skyline. Reflecting on past 4 years and what we have built is hard to believe. We are just getting started. Thank you to the best team I have ever worked with 🙏

Our book chapter on LDRT for painful musculoskeletal conditions has now been published. You can find in the latest Advances in Oncology.

Our team is working on a project on the pharmacologic management of #RadOnc toxicities. The end product will be a modern web/phone-friendly version of the 2007 Dziuk book, akin to https://t.co/Oa1xVpneCa We're also writing a review article. Please message me if you want to join.

As we look back and reflect on a year of growth, innovation, and collaboration. 2024's achievements have brought us closer to our mission of advancing patient care and operational excellence. Thank you to our clients and partners for making this success possible—here’s to an